Stryker Corporation Completes Public Offering of NotesOn February 10, 2025, Stryker Corporation (NYSE: SYK) finalized a public offering of $500 million aggregate principal amount of its 4.550% Notes due 2027, $700 million aggregate principal amount o

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Stryker’s 8K filing here.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.